<bill session="112" type="s" number="3232" updated="2013-07-20T02:44:31-04:00">
  <state datetime="2012-05-23">REFERRED</state>
  <status>
    <introduced datetime="2012-05-23"/>
  </status>
  <introduced datetime="2012-05-23"/>
  <titles>
    <title as="introduced" type="official">A bill to amend the Internal Revenue Code of 1986 and the Patient Protection and Affordable Care Act to extend, expand, and improve the qualifying therapeutic discovery project program.</title>
  </titles>
  <sponsor id="400272"/>
  <cosponsors/>
  <actions>
    <action state="REFERRED" datetime="2012-05-23">
      <text>Read twice and referred to the Committee on Finance.</text>
    </action>
  </actions>
  <committees>
    <committee code="SSFI" name="Senate Finance" activity="Referral, In Committee"/>
  </committees>
  <relatedbills/>
  <subjects>
    <term name="Taxation"/>
    <term name="Health programs administration and funding"/>
    <term name="Health promotion and preventive care"/>
    <term name="Income tax credits"/>
    <term name="Medical research"/>
  </subjects>
  <amendments/>
  <summary>5/23/2012--Introduced.
Amends the Internal Revenue Code and the Patient Protection and Affordable Care Act, with respect to the tax credit for the qualifying therapeutic discovery project program, to: (1) extend such credit and credit allocations through 2012; (2) increase the total amount of credits allocable to $2 billion for the 4-year period beginning with 2009; (3)&#160;extend from 30 to 90 days the period for review of applications for certification of investments under such program and the time for making payments to&#160;applicants; and (4) modify the criteria used by the Secretary of the Treasury for selecting program projects to require the selection of projects&#160;that show significant potential (currently, reasonable potential).</summary>
</bill>
